Skip to main content

Table 3 Description of patients before and after matching with patients with respiratory failure from other etiologies

From: Prognosis of critically ill immunocompromised patients with virus-detected acute respiratory failure

 

Before matching

After matching

Viral–ARF

N = 370

Other ARF

N = 2697

Absolute standardized mean difference

Other ARF

N = 1110

Absolute standardized mean difference

Age, years

60 (14)

60 (15)

0.004

60 (15)

0.014

Female gender

147 (39)

1018 (38)

0.036

418 (38)

0.037

Chronic respiratory disease

61 (17)

604 (24)

0.176

235 (23)

0.135

Tobacco use

66 (23)

642 (33)

0.222

241 (32)

0.214

Charlson score

4 (2)

5 (3)

0.319

5 (3)

0.209

PS score ≥ 2

141 (43)

1124 (49)

0.119

492 (50)

0.138

Underlying conditions

 Immunosuppression category

  

0.465

 

0.039

 Hematological malignancy

234 (63)

1589 (59)

 

673 (60)

 

  Acute leukemia

69 (19)

705 (26)

 

224 (20)

 

  Lymphoma

82 (22)

565 (21)

 

269 (24)

 

  Multiple myeloma

68 (18)

181 (7)

 

107 (9)

 

  Others

15 (4)

138 (5)

 

73 (6)

 

 Solid tumor

52 (23)

685 (25)

 

261(23)

 

 Other

84 (14)

423 (16)

 

176 (16)

 

  Solid organ transplant

40 (11)

226 (8)

 

105 (14)

 

  Drugs

44 (12)

685 (7)

 

156 (9)

 

 Allogeneic–HCT

57 (15)

265 (10)

 

161 (15)

 

 Neutropenia

146 (40)

820 (30)

0.191

407 (37)

0.058

ICU admission

 Invasive mechanical ventilation

95 (26)

714 (27)

0.027

268 (24.5)

0.028

 NIV

105 (28)

658 (25)

0.089

258 (23)

0.116

 High-flow oxygen

116 (31)

643 (24)

0.169

369 (33)

0.040

 PaO2/FiO2, mmHg

141 (67)

165 (91)

0.302

140 (66)

0.013

 SOFA score

7 (4)

7 (4)

0.032

7 (4)

0.002

ICU stay

 Invasive mechanical ventilation (overall)

141 (38)

1239 (46)

0.160

488 (44)

0.120

 Vasopressor support

202 (55)

1454 (54)

0.013

597 (54)

0.014

 RRT

64 (17)

522 (19)

0.055

189 (17)

0.004

Outcomes

 Treatment withdrawal

103 (28)

738 (27)

0.009

317 (29)

0.018

 Invasive mechanical ventilation duration, days

14 (14)

8 (14)

0.076

13 (17)

0.021

 ICU length of stay, days

15 (26)

11 (15)

0.195

11 (13)

0.215

 Hospital length of stay, days

24 (16.53)

27 (25)

0.129

29 (28)

0.238

 In ICU Mortality

113 (31)

839 (31)

0.012

359 (32)

0.039

 In hospital Mortality

140 (38)

1161 (43)

0.106

490 (44)

0.128

  1. Results are presented as N (%) and mean (SD). Absolute standardized mean difference (SMD) is the absolute value of the difference in mean between groups divided by standard deviation. An absolute standardized mean difference of less than 0.2 usually shows a balance between groups
  2. Allogeneic–HCT: allogeneic hematopoietic stem-cell transplantation; ARF: acute respiratory failure; ICU: intensive care unit; NIV: non-invasive ventilation; PS score: Performance Status score; RRT: renal replacement therapy; SMD: Standardized Mean Differences; SOFA score: Sepsis Organ Failure Assessment score; SOT: solid organ transplant